Dr. Armand P. Ferro, ASM's Epitaxial Business Unit Manager stated, "This successful implementation of multiple silicon germanium processes on the new 300mm RP Epsilon is an important step in making our most advanced production processes available to our 300mm customers. SiGe epitaxy is primarily used for advanced high frequency device applications and now, with 300mm capability, ASM is able to better serve our customers' most sophisticated 300mm epitaxial needs."
ASM is a world-class supplier of single-wafer epitaxial tools and related semiconductor process equipment. ASM has been building and selling epitaxial reactors since 1987 and its Epsilon reactors are used in mass production by all major semiconductor device manufacturers and wafer suppliers worldwide.
About ASM
ASM International is headquartered in Bilthoven, the Netherlands. ASM International's subsidiaries design, develop, manufacture and market equipment and materials used to produce semiconductor devices. ASM International and its subsidiaries provide production solutions for the wafer processing, assembly and packaging segments of the semiconductor equipment market through their facilities in the United States, Europe, Japan and Asia. ASM International's common shares trade on the NASDAQ National Market and on the AEX Stock Exchange in Amsterdam under the symbol "ASM". More information on ASM can be found on its website at http://www.asm.com
# # #
Safe Harbor Statement under the US Private Securities Litigation Reform Act of 1995: The statements regarding orders, earnings developments and the effects of research and new products on ASM's future, and other matters discussed in its statement, except for any historical data, are forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These include, but are not limited to economic conditions in the semiconductor industry, currency fluctuations, the timing of significant orders, market acceptance of new products, competitive factors, risk factors related to litigation and other risks indicated in filings from time to time with the SEC and the Stock Exchange Authorities.